Valvular heart disease associated with fenfluramine-phentermine - Wikidata - awgldk - TriplyDB

Valvular heart disease associated with fenfluramine-phentermine

Valvular heart disease associated with fenfluramine-phentermine

http://www.wikidata.org/entity/Q28247282

about

Benfluorex and unexplained valvular heart disease: a case-control study Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals Risk of valvular heart disease associated with use of fenfluramine Pharmacotherapies for obesity: past, current, and future therapies Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA)Long-term drug treatment for obesity: a systematic and clinical review Long-term pharmacotherapy for obesity and overweight Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)Anti-Obesity Drugs: A Review about Their Effects and Safety Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction Serotonergic drugs and valvular heart disease Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells Obesity: an overview on its current perspectives and treatment options Weight-modification trials in older adults: what should the outcome measure be?Appetite suppressants and valvular heart disease - a systematic review.The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity Weight management in obesity - past and present Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS)The New Era of Drug Therapy for Obesity: The Evidence and the Expectations Application of cross-species PET imaging to assess neurotransmitter release in brain Neural control of energy balance: translating circuits to therapies Structural Basis for Molecular Recognition at Serotonin Receptors Creation of a free, Internet-accessible database: the Multiple Target Ligand Database Non-proliferative and Proliferative Lesions of the Cardiovascular System of the Rat and Mouse Efficacy comparison of medications approved for chronic weight management Next generation of weight management medications: implications for diabetes and CVD risk Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs The longitudinal effects of fenfluramine-phentermine use Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine(2B) receptor agonists: implications for drug safety assessment Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity Beneficial effects of pharmacotherapy on weight loss, depressive symptoms, and eating patterns in obese binge eaters and non-binge eaters Pharmaceutical cost savings of treating obesity with weight loss medications Echocardiographic evidence for valvular toxicity of benfluorex: a double-blind randomised trial in patients with type 2 diabetes mellitus Regulation of heart valve morphogenesis by Eph receptor ligand, ephrin-A1 A serotonin and melanocortin circuit mediates D-fenfluramine anorexia Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012 Serotonin 2C receptor activates a distinct population of arcuate pro-opiomelanocortin neurons via TRPC channels

P2860

Q21091138-D889704B-A05A-48CB-B4F3-74FDA647A837 Q21245270-A56DE3CB-562F-4C6E-B273-C657785C7B4B Q21261946-F0474C22-12F7-4234-A36E-5520FEFB1279 Q21296814-9BCC6E17-8AD8-48B5-92A5-BADF2E0C5244 Q22251113-9D97BB63-2D65-4EC5-A599-E056D67B9907 Q22253010-22885CB6-B4B1-458A-A5E3-2F63DA037293 Q24247723-777478CA-5197-4187-BE74-96AD3350104C Q24619949-F76FC566-F308-4F68-B2FC-26FEDD34BB72 Q24630947-72EB2C34-011A-4D70-9905-32A264E1A63F Q24641896-C63ED21D-19B9-4C7D-8C4A-41C6C37BD62F Q24646869-27334DEF-17DD-4D44-864F-A619E2344AAA Q24658031-919960FE-D4A8-4F87-B6CF-509FF9639B81 Q24685016-9CCDB292-9AF1-4150-B9A9-64398F80072B Q24792455-02FAEB5D-BA6A-46E4-9920-5022406F84F1 Q24794214-37417409-A1BE-4166-9306-179CD45C61C2 Q24802870-51A8E7E2-3FAE-4AF2-9DB0-6490316150B8 Q26765609-47F8FFE5-C19C-43E4-862F-A33C17AD4ACD Q26774747-C558E1CA-DE09-4251-BEC0-A1EFA65B5AFA Q26776222-E53B037A-BED3-478C-8EB3-40CA830419DA Q26799634-5072F216-E534-433B-8AFE-2A1410DAFECD Q26827555-FB55F7A5-A311-49E8-895C-3CAFCC7A08B1 Q26865012-25F31010-A298-4ED3-8BD0-470B54CD7897 Q27005992-454FEBD2-C36E-4385-8021-0BE122AED4FA Q27676926-8FFF7657-2129-40BC-9C38-B9AC517BC342 Q27902291-151EB0FE-5365-43AC-B8E4-0C1D370BBA3F Q28079801-F36EC46C-1282-4E53-8740-CB3F83E62057 Q28081944-EF555E79-CD46-495B-BC87-0C77B2E03594 Q28082858-EF230321-06E0-4549-9B28-B3B4B5AB966A Q28088311-4712593F-F82F-45C5-995F-D98C6D23914D Q28236300-260F0E89-13F3-4D55-861F-8CF35C2433DC Q28250560-BF38FC8C-2D98-4B99-A8B6-E221F83567FF Q28365866-BA95FD83-E052-49B7-9AB4-E10E65F31631 Q28373048-DE0DD08D-2311-4BE6-AC87-F9AE4DF178A0 Q28373521-3D7CAA59-910F-48BB-A5C7-99A75613911D Q28376988-89310700-7AB9-4AA3-8C03-A9BF1DC70928 Q28480527-8BDD1FE0-A0C0-4E4D-8384-4397AC80E1B2 Q28504714-478D8E62-7B7F-4A6A-A359-5F3AF0238301 Q28506385-DFB0D488-A7AD-4365-A102-97C730797B03 Q28552890-F4FF676A-5DD4-468C-8F60-1B3CB888422D Q28585910-8D52C58D-1840-4F68-8534-D31F673AA229

P2860

Valvular heart disease associated with fenfluramine-phentermine

http://www.wikidata.org/entity/Q28247282

description

1997 nî lūn-bûn

@nan

1997 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

1997 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

name

Valvular heart disease associated with fenfluramine-phentermine

@ast

Valvular heart disease associated with fenfluramine-phentermine

@en

Valvular heart disease associated with fenfluramine-phentermine

@nl

type

label

Valvular heart disease associated with fenfluramine-phentermine

@ast

Valvular heart disease associated with fenfluramine-phentermine

@en

Valvular heart disease associated with fenfluramine-phentermine

@nl

prefLabel

Valvular heart disease associated with fenfluramine-phentermine

@ast

Valvular heart disease associated with fenfluramine-phentermine

@en

Valvular heart disease associated with fenfluramine-phentermine

@nl

P1433

Q28247282-924C77A2-CAB7-42A9-A425-9608A34A3E5C

P1476

Q28247282-E708DD5D-6A3F-4DCB-B202-D982C540975C

P2093

Q28247282-15E429E7-4B3F-43B2-BECE-2830066C7898

Q28247282-3F82DD2C-5E8A-42FC-9592-CFFF7E28E114

Q28247282-86B875B8-41FD-4AE6-B96F-B0B19142FDA9

Q28247282-9CD5A3B7-68C8-4727-8A7D-3B96B0511017

Q28247282-A14B6397-DC00-471B-ADFE-F2F13FE996D2

Q28247282-B1191F29-8ED5-4528-8FC7-C1BC68F93956

Q28247282-C61F74A8-E2BF-45F7-A0CB-26BB548495ED

P304

Q28247282-1B596CC0-FD32-462D-B1C4-A11156C8C958

P31

Q28247282-634D846F-0D85-405F-83DE-3170AB750A1D

P3181

Q28247282-1CDCFE21-8AFB-4C2E-8F72-CF2AFBDA16E7

P356

Q28247282-24E58ACD-223C-4D61-A454-14BE06C4FE85

P407

Q28247282-72450C0C-DC0F-49FA-BF55-CF6524EEE007

P433

Q28247282-739150EE-D2FA-4FF5-8BB3-2B7ED1C28108

P478

Q28247282-B3E30E30-8070-493A-B073-64F4A9209A88

P577

Q28247282-A3530B7B-5F13-4C01-8276-3554E90397DB

P698

Q28247282-5E3D8C9B-227B-4906-949E-BC8CEF2C7876

P3181

P356

NEJM199708283370901

P1433

The New England Journal of Medicine

P1476

Valvular heart disease associated with fenfluramine-phentermine

@en

P2093

B S Edwards

http://www.w3.org/2001/XMLSchema#string

D D Hensrud

http://www.w3.org/2001/XMLSchema#string

H M Connolly

http://www.w3.org/2001/XMLSchema#string

H V Schaff

http://www.w3.org/2001/XMLSchema#string

J L Crary

http://www.w3.org/2001/XMLSchema#string

M D McGoon

http://www.w3.org/2001/XMLSchema#string

W D Edwards

http://www.w3.org/2001/XMLSchema#string

P304

581-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4224562

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJM199708283370901

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

337

http://www.w3.org/2001/XMLSchema#string

P577

1997-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9271479

http://www.w3.org/2001/XMLSchema#string